Skip to main content

We Treat Hep C - Resources for Michigan Providers

Documents are undergoing accessibility remediation and may not be fully compatible with screen reading software at this time. If you are using screen reading software and need additional information, please contact MDHHS-BIDP@michigan.gov.

Image of 3 providers with the words "Test. Treat. Cure" above them
Join the effort to eliminate Hep C in all Michiganders

Any provider with prescriptive authority can cure hepatitis C. Through the Michigan Department of Health and Human Services' We Treat Hep C Initiative, Medicaid and Healthy Michigan Plan beneficiaries living with hepatitis C can be cured at little to no cost regardless of the prescriber's specialty, patient's past or current use of alcohol or drugs, or liver damage.

Prior Authorization *Fibrosis Restrictions Patient Abstinence from Alcohol & Drugs Specialist Prescriber Age (Years)
MAVYRET®** (glecaprevir/pibrentasvir) Not required None Not required Not required 3+
Other non-preferred HCV DAAs Standard Medicaid clinical prior authorization form None Not required Not required Administration and dosage vary for each DAA. Please see full prescribing information.

*While liver fibrosis assessment is essential for all patients, submission of fibrosis score is no longer required for treatment coverage under Medicaid/Healthy Michigan plans.

** Providers should order the entire course of Mavyret® indicating an 8- or 12-week supply.

  • Specialty or retail pharmacies are authorized to dispense up to 102 days of therapy at a single time but default to dispensing in 4-week increments unless otherwise indicated.

Learn about Hepatitis C testing and treatment

FAQ - Frequently asked questions on We Treat Hep C, including clinical questions.

We Treat Hep C Clinician Newsletter (October 2025) - Clinical newsletter highlighting the new We Treat Hep C: Impact on Hepatitis C in Michigan fact sheet, the 2024 Viral Hepatitis Surveillance Report, MDHHS harm reduction modeling study, SAMHSA HCV Elimination Initiative Pilot recipients, and World Hepatitis Testing Week. This newsletter also features a clinical spotlight on Jill Davenport, nurse practitioner with Great Lakes Bay Health Center who specializes in providing hepatitis C treatment, family practice and primary care, psychiatric/mental health care, behavioral health, and MAT. 

We Treat Hep C Clinician Newsletter (July 2025) - Clinical newsletter highlighting the new AASLD/IDSA HCV Point-of-Care Test and Treat Algorithm, World Hepatitis Day, the Cure Hepatitis C Act of 2025, and the SAMHSA HCV Elimination Pilot funding opportunity. This newsletter also includes a provider spotlight featuring Dr. Craig Weeks, a family medicine/primary care physician who also offers specialty care in HIV, viral hepatitis, and treatment of opiate use disorders. 

We Treat Hep C Clinician Newsletter (April 2025) - Clinical newsletter highlighting the Michigan Syringe Service Program Directory, free naloxone through MDHHS, and save the date for the 2025 Michigan Harm Reduction Summit. This newsletter includes a clinical spotlight featuring Lauren Judd, a nurse practitioner specializing in addiction medicine and treatment of infectious diseases (including hepatitis C) at Detroit Recovery Project, offering a variety of critical services via outreach on their mobile unit. 

We Treat Hep C Clinician Newsletter (November 2024) - Clinical newsletter highlighting the first FDA-approved point-of-care hepatitis C RNA test, upcoming hepatitis C webinars and new educational materials, and spotlighting Michelle Thorne, a nurse practitioner specializing in family medicine and hepatitis C treatment at Calhoun County Public Health Department. 

We Treat Hep C Clinician Newsletter (July 2024) - Clinical newsletter highlighting the importance of testing for hepatitis C during pregnancy, perinatal hepatitis C testing recommendations, and spotlighting Dr. Jennifer Hoffman and Dr. Lori Burke, physicians offering comprehensive addiction medicine services (including hepatitis C treatment) and gynecologic care. 

We Treat Hep C Clinician Newsletter (March 2024) - Clinical newsletter highlighting Michigan's statewide initiative to eliminate hepatitis C among Michigan Medicaid and Healthy Michigan Plan beneficiaries by removing barriers to curing hepatitis C, highlighting adult universal hepatitis C testing recommendations, and spotlighting Dr. Elaine Engelsman, a nurse practitioner specializing in the treatment of infectious diseases, including hepatitis C.